Verition Fund Management
AMGN icon

Verition Fund Management’s Amgen AMGN Stock Holding History

Verition Fund Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Sell
6,900
-300
-4% -$103K 0.01% 993
2026
Q1 		$2.53M Buy
7,200
+3,300
+85% +$1.18M 0.02% 898
2025
Q4 		$1.28M Sell
3,900
-11,500
-75% -$3.65M 0.01% 1966
2025
Q3 		$4.35M Buy
15,400
+2,800
+22% +$812K 0.02% 1299
2025
Q2 		$3.52M Buy
12,600
+5,300
+73% +$1.5M 0.02% 1464
2025
Q1 		$2.27M Buy
+7,300
New +$2.16M 0.01% 1478
2024
Q3 		– Sell
-1,500
Closed -$469K – 3158
2024
Q2 		$469K Buy
+1,500
New +$441K ﹤0.01% 2084
2023
Q1 		– Sell
-14,400
Closed -$3.78M – 2135
2022
Q4 		$3.78M Sell
14,400
-400
-3% -$107K 0.06% 409
2022
Q3 		$3.34M Buy
+14,800
New +$3.59M 0.04% 619
2022
Q2 		– Sell
-19,200
Closed -$4.64M – 2318
2022
Q1 		$4.64M Buy
19,200
+7,400
+63% +$1.7M 0.06% 424
2021
Q4 		$2.65M Buy
+11,800
New +$2.49M 0.02% 691

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Verition Fund Management's AMGN Position: Q2 2026 in Review

Verition Fund Management reduced its Amgen (AMGN) stake by 61% in Q2 2026, selling an estimated $943K and leaving 1,789 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Verition Fund Management first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $15.2M in Q3 2025. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Verition Fund Management held 1,789 shares of Amgen worth $648K as of Q2 2026.
  • Verition Fund Management sold 2,755 Amgen shares in Q2 2026, an estimated $943K.
  • Amgen made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1573 holding.
  • Verition Fund Management first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
  • Verition Fund Management's Amgen position peaked at $15.2M in Q3 2025.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.